Botulinum toxin A for the treatment of first bite syndrome

Abstract

We read with colossal interest the manuscript of Shaikh et al. entitled “Botulinum toxin A for the treatment of first bite syndrome—a systematic review” (1). The authors’ systematic review results suggest that botulinum toxin (BT) A can be a potentially safe, effective treatment for the First bite Syndrome (FBS). The MEDLINE, Embase, Cochrane Base (CENTRAL), and Google Scholar were searched from inception until July 2020. Search results yielded 41 studies. There were no reported injection complications, including facial paralysis, infection, injection site reaction, and allergic reaction.